Oric Pharmaceuticals (ORIC) Earnings Date & Reports

A.I. Advisor

published Earnings

ORIC is expected to report earnings to rise 6.04% to -47 cents per share on November 04

Oric Pharmaceuticals ORIC Stock Earnings Reports

Q3'24

Est.

$-0.48

Q2'24

Missed

by $0.04

Q1'24

Beat

by $0.05

Q4'23

Missed

by $0.01

Q3'23

Beat

by $0.02

The last earnings report on August 12 showed earnings per share of -44 cents, missing the estimate of -40 cents. With 312.01K shares outstanding, the current market capitalization sits at 668.04M.

View a ticker or compare two or three

Compare

ORIC

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ORIC
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ORIC (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

240 E. Grand Avenue

Phone

+1 650 388-5600

Employees

100

Web